ReviewMolecular therapy. Methods & clinical development2025

Risks of replication-competent retro/lentivirus from associated vector systems: Is it time for a roadmap toward reduced testing?

Daniel Farley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.